Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 67 (2017): Issue 2 (June 2017)
Open Access
Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels
Lourdes A. Vega Rasgado
Lourdes A. Vega Rasgado
,
Iván Villanueva
Iván Villanueva
and
Fernando Vega Díaz
Fernando Vega Díaz
| Jun 01, 2017
Acta Pharmaceutica
Volume 67 (2017): Issue 2 (June 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original research paper
Published Online:
Jun 01, 2017
Page range:
215 - 226
Accepted:
Dec 16, 2016
DOI:
https://doi.org/10.1515/acph-2017-0014
Keywords
γ-ethyl-γ-phenyl-butyrolactone (EFBL)
,
anticonvulsant
,
hypnotic
,
mouse brain
,
catecholamine
© by Lourdes A. Vega Rasgado
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.